Prexton

Prexton Portfolio

Prexton is a clinical stage biotech that is developing novel treatments for the debilitating symptoms of late stage Parkinson’s disease. Prexton was acquired by Lundbeck in March 2018.

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top